{
    "doi": "https://doi.org/10.1182/blood-2021-152420",
    "article_title": "Peripheral Blasts Are Associated with Response to Ruxolitinib and Outcome in Patients with Chronic-Phase Myelofibrosis ",
    "article_date": "November 5, 2021",
    "session_type": "634.Myeloproliferative Syndromes: Clinical and Epidemiological",
    "abstract_text": "Background: The presence of peripheral blasts (PB) is a negative prognostic factor in patients (pts) with primary and secondary myelofibrosis (PMF/SMF) and PB \u22654% was associated with a particularly unfavorable prognosis ( Masarova L et al, Cancer 2020 ). Ruxolitinib (RUX) is the JAK1/2 inhibitor most used for treatment of MF-related splenomegaly and symptoms. Its role has not been assessed in correlation with PB. Aims: To evaluate the impact of PB percentage on RUX efficacy and prognosis Methods: After IRB approval, the \"RUX-MF\" retrospective study collected 804 RUX-treated chronic-phase (CP, defined as PB <10%) pts in 26 Hematology Centers. In 794 pts, PB count was evaluated by morphology at RUX start and correlated with treatment success and outcome. Risk category was assessed according to DIPSS ( Passamonti F et al, Blood. 2010 ). Spleen (SR) and symptoms (SyR) response were assessed using IWG-MRT criteria ( Tefferi A et al, Blood. 2013 ). Comparisons of quantitative variables between the 3 groups were carried out by Kruskal-Wallis and Dunn's tests while association between categorical variables was tested by the \u03c72 test. Variables significantly associated to RUX stop/leukemic transformation (LT)/overall survival (OS) in univariate analysis (Log-rank test) were considered for multivariable analyses, carried out using the Cox regression model, with evaluation of the model's performance in terms of goodness of fit. Results: Pts were categorized according to PB at RUX start: PB-0 (no PB; n. 487, 61.3%), PB-5 (PB 1-5%; n. 283, 35.8%), and PB-9 (PB 6-9%; n. 24, 2.9%). Pts characteristics at RUX start were: median age 68.1y (24-89); males 58.1%; PMF 52.5%; JAK2, CALR and MPL mutated: 80.5%, 13.1% and 2% (4.4% triple negative), high DIPSS: 7.6%; PLT25 x10 9 /l: 10.8%/16.4%; spleen length \u226510 cm: 47.8%, TSS \u226520: 60.6%; \u22651/\u22652 high-risk mutation (HMR): 69/18 out of 167 evaluable (41.3%/10.8%); fibrosis grade \u22652: 77.9%; starting/cumulative RUX dose \u226515 mg BID: 61.4%/52.6%. Higher PB count was associated to high DIPSS risk (PB-0: 1.9%, PB-5: 16.2%, PB-9: 21.7%, p<0.001), PLT<100 x10 9 /l (PB-0: 17.6%, PB-5: 15.1%, PB-9: 26.1%, p<0.001), fibrosis grade \u22652 (PB-0: 73.3%, PB-5: 84.2%, PB-9: 100%, p<0.001), spleen length \u226510 cm (PB-0: 43%, PB-5: 55.1%, PB-9: 59.1%, p=0.003). At 3 and 6 mos, 26.9% and 30.4% of evaluable pts achieved a SR, while 59.7% and 68.1% were in SyR, respectively. At 3 mos, SR (PB-0: 31.8%, PB-5: 20.6%, PB-9: 10%, p=0.001) and SyR (PB-0: 62.9%, PB-5: 55.5%, PB-9: 36.8%, p=0.02) were less frequently achieved by PB-5 and PB-9 pts compared to PB-0 pts. This association remained significant for SR at 6 mos (PB-0: 35%, PB-5: 23.9%, PB-9: 14.3%, p=0.006) and for both SR (p=0.003) and SyR (p=0.01) at any time. After a median RUX exposure of 1.5 y (0.1-8.9), 491 (61.8%) pts stopped RUX, 110 (13.9%) had a LT and 365 (46%) died. In univariate analysis, at 2y PB-9 pts had higher rates of RUX stop (73.9% vs 40.8% and 34.3% in PB-5 and PB-0 pts, log-rank p<0.001) and LT (38.5% vs 10.2% and 6.2% in PB-5 and PB-0 pts, log-rank p=0.003). Median survival times of PB-0, PB-5 and PB-9 patients were 5.8, 4.9 and 2 years, respectively (log-rank p<0.001) ( Figure 1 ). In multivariable analysis, PB-9 pts confirmed their association with: 1) RUX stop (HR 3.74, 95%CI 1.51-3.70, p20 (HR 1.66, 95%CI 1.05-2.61, p=0.03), and HMR\u22652 (HR 2.69, 95%CI 1.26-4.47, p=0.007); 2) LT (HR 3.71, 95%CI 1.71-8.04, p<0.001), with HMR\u22652 (HR 7.10, 95%CI 2.28-22.1, p<0.001); 3) OS (HR 2.40, 95%CI 1.60-3.60, p<0.001), with age\u226565 (HR 2.31, 95%CI 1.17-4.57, p=0.02) and HMR\u22652 (HR 3.21, 95%CI 1.67-6.20, p<0.001). Unfavorable association with LT and OS was confirmed also in patients with HMR\u22651. Conclusions: CP-MF pts with PB>5% have a worse response to RUX and a worse outcome. Personalized approaches beyond RUX monotherapy may be useful in this context. Further clinical trials evaluating combination strategies and new drugs are required. Figure 1 View large Download slide Figure 1 View large Download slide Close modal Disclosures Palandri:  Novartis: Membership on an entity's Board of Directors or advisory committees; Celgene: Membership on an entity's Board of Directors or advisory committees; AOP: Membership on an entity's Board of Directors or advisory committees; Sierra Oncology: Membership on an entity's Board of Directors or advisory committees; CTI: Consultancy. Abruzzese:  Bristol Myers Squibb: Consultancy, Honoraria; Incyte: Consultancy, Honoraria; Novartis: Consultancy, Honoraria; Pfizer: Consultancy, Honoraria. Iurlo:  Bristol Myers Squibb: Speakers Bureau; Pfizer: Speakers Bureau; Novartis: Speakers Bureau; Incyte: Speakers Bureau. Bonifacio:  Bristol Myers Squibb: Honoraria; Novartis: Honoraria; Pfizer: Honoraria; Amgen: Honoraria. Cuneo:  AbbVie: Consultancy, Speakers Bureau; AstraZeneca: Consultancy, Speakers Bureau; Janssen: Consultancy, Speakers Bureau; Gilead: Consultancy, Speakers Bureau. Pane:  AbbVie; Amgen; Novartis: Other: Travel, accommodation, expenses; Novartis Pharma SAS;: Research Funding; AbbVie; Amgen; Novartis, GSK , Incyte: Consultancy; AbbVie; Amgen; Novartis, GSK, Incyte: Speakers Bureau. Lemoli:  Celgene: Other: Support for attending meetings and/or travel; Jazz, Janssen: Honoraria, Membership on an entity's Board of Directors or advisory committees, Speakers Bureau; AbbVie, Daiichi Sankyo, Servier: Honoraria, Speakers Bureau. Cavo:  Bristol-Myers Squib: Consultancy, Honoraria, Membership on an entity's Board of Directors or advisory committees, Speakers Bureau; Novartis: Honoraria; Amgen: Consultancy, Honoraria, Membership on an entity's Board of Directors or advisory committees, Speakers Bureau; Takeda: Consultancy, Honoraria, Membership on an entity's Board of Directors or advisory committees, Speakers Bureau; Janssen: Consultancy, Honoraria, Membership on an entity's Board of Directors or advisory committees, Other: TRAVEL, ACCOMMODATIONS, EXPENSES, Speakers Bureau; Adaptive Biotechnologies: Consultancy, Honoraria; Celgene: Consultancy, Honoraria, Membership on an entity's Board of Directors or advisory committees, Other: Travel Accommodations, Speakers Bureau; GlaxoSmithKline: Consultancy, Honoraria; Sanofi: Consultancy, Honoraria, Membership on an entity's Board of Directors or advisory committees, Speakers Bureau; AbbVie: Consultancy, Honoraria, Membership on an entity's Board of Directors or advisory committees. Breccia:  Novartis: Honoraria; Pfizer: Honoraria; Incyte: Honoraria; Bristol Myers Squibb/Celgene: Honoraria; Abbvie: Honoraria.",
    "author_names": [
        "Francesca Palandri",
        "Daniela Bartoletti",
        "Elisabetta Abruzzese",
        "Alessandra Iurlo",
        "Massimiliano Bonifacio",
        "Giovanni Caocci",
        "Elena Maria Elli",
        "Giuseppe Auteri",
        "Mario Tiribelli",
        "Nicola Polverelli",
        "Bruno Martino",
        "Maurizio Miglino",
        "Florian H. Heidel",
        "Alessia Tieghi",
        "Giulia Benevolo",
        "Eloise Beggiato",
        "Carmen Fava",
        "Francesco Cavazzini",
        "Novella Pugliese",
        "Gianni Binotto",
        "Costanza Bosi",
        "Monica Crugnola",
        "Emanuela Ottaviani",
        "Christian Di Pietro",
        "Giorgia Micucci",
        "Malgorzata Monika Trawinska",
        "Antonio Cuneo",
        "Monica Bocchia",
        "Mauro Krampera",
        "Fabrizio Pane",
        "Roberto M. Lemoli",
        "Daniela Cilloni",
        "Michele Cavo",
        "Nicola Vianelli",
        "Giuseppe A. Palumbo",
        "Massimo Breccia"
    ],
    "author_dict_list": [
        {
            "author_name": "Francesca Palandri",
            "author_affiliations": [
                "IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia \"Ser\u00e0gnoli\", Bologna, Italy"
            ],
            "author_rank": 1,
            "first_author": 1,
            "last_author": 0
        },
        {
            "author_name": "Daniela Bartoletti",
            "author_affiliations": [
                "IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia \"Ser\u00e0gnoli\", Bologna, Italy",
                "Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale, Universit\u00e0 di Bologna, Bologna, Italy"
            ],
            "author_rank": 2,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Elisabetta Abruzzese",
            "author_affiliations": [
                "Hematology, S. Eugenio Hospital, Tor Vergata University, Rome, Italy"
            ],
            "author_rank": 3,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Alessandra Iurlo",
            "author_affiliations": [
                "Hematology Division, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy"
            ],
            "author_rank": 4,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Massimiliano Bonifacio",
            "author_affiliations": [
                "Azienda Ospedaliera Universitaria Integrata, Policlinico G. Rossi, Verona, Italy"
            ],
            "author_rank": 5,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Giovanni Caocci",
            "author_affiliations": [
                "Department of Medical Sciences and Public Health, University of Cagliari, Businco Hospital, Cagliari, Italy"
            ],
            "author_rank": 6,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Elena Maria Elli",
            "author_affiliations": [
                "Hematology Division and Bone Marrow Transplant Unit, San Gerardo Hospital, ASST Monza, Monza, Italy"
            ],
            "author_rank": 7,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Giuseppe Auteri",
            "author_affiliations": [
                "IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia \"Ser\u00e0gnoli\", Bologna, Italy",
                "Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale, Universit\u00e0 di Bologna, Bologna, Italy"
            ],
            "author_rank": 8,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Mario Tiribelli",
            "author_affiliations": [
                "Division of Hematology and Stem Cell Transplantation, Azienda Sanitaria Universitaria Integrata, Udine, Italy"
            ],
            "author_rank": 9,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Nicola Polverelli",
            "author_affiliations": [
                "Bone Marrow Transplant Unit, ASST-Spedali Civili di Brescia, Chair of Hematology, Dpt of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy"
            ],
            "author_rank": 10,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Bruno Martino",
            "author_affiliations": [
                "Hematology Unit, A.O. Bianchi-Melacrino-Morelli, Reggio Calabria, Italy"
            ],
            "author_rank": 11,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Maurizio Miglino",
            "author_affiliations": [
                "Dipartimento di Medicina interna e Specialit\u00e0 mediche, Universit\u00e0 di Genova, Genova, Italy",
                "Clinic of Hematology, Department of Internal Medicine (DiMI), IRCCS Ospedale Policlinico San Martino, Genova, Italy"
            ],
            "author_rank": 12,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Florian H. Heidel",
            "author_affiliations": [
                "Fritz-Lipmann Institute, Leibniz Institute on Aging, Jena, Germany",
                "Innere Medicine C, Universit\u00e4tsmedizin Greifswald, Greifswald, Germany"
            ],
            "author_rank": 13,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Alessia Tieghi",
            "author_affiliations": [
                "Department of Hematology, Azienda USL - IRCCS di Reggio Emilia, Reggio Emilia, Reggio Emilia, Italy"
            ],
            "author_rank": 14,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Giulia Benevolo",
            "author_affiliations": [
                "Division of Hematology, AOU \"Citt\u00e0 della Salute e della Scienza di Torino\", Turin, Italy"
            ],
            "author_rank": 15,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Eloise Beggiato",
            "author_affiliations": [
                "Unit of Hematology, Department of Oncology, University of Torino, Torino, Italy"
            ],
            "author_rank": 16,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Carmen Fava",
            "author_affiliations": [
                "A.O. Ordine Mauriziano di Torino, Torino, Italy, Turin, Italy"
            ],
            "author_rank": 17,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Francesco Cavazzini",
            "author_affiliations": [
                "Division of Hematology, Department of Medical Sciences, University of Ferrara, Azienda Ospedaliera-Universitaria, Arcispedale S. Anna, Ferrara, Italy"
            ],
            "author_rank": 18,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Novella Pugliese",
            "author_affiliations": [
                "Hematology - Department of Clinical Medicine and Surgery, University Federico II, Naples, Italy"
            ],
            "author_rank": 19,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Gianni Binotto",
            "author_affiliations": [
                "Hematology Unit, Azienda Ospedaliera di Padova, University of Padova, Padova, Italy"
            ],
            "author_rank": 20,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Costanza Bosi",
            "author_affiliations": [
                "Hematology section, AUSL di Piacenza, piacenza, Italy"
            ],
            "author_rank": 21,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Monica Crugnola",
            "author_affiliations": [
                "Division of Hematology, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy"
            ],
            "author_rank": 22,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Emanuela Ottaviani",
            "author_affiliations": [
                "IRCCS Azienda ospedaliero-universitaria di Bologna, Istituto di Ematologia \"Ser\u00e0gnoli\", Bologna, Italy"
            ],
            "author_rank": 23,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Christian Di Pietro",
            "author_affiliations": [
                "IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia \"Ser\u00e0gnoli\", Bologna, Italy",
                "Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale, Universit\u00e0 di Bologna, Bologna, Italy"
            ],
            "author_rank": 24,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Giorgia Micucci",
            "author_affiliations": [
                "Hematology and Stem Cell Transplant Center, AORMN Hospital, Pesaro, Italy"
            ],
            "author_rank": 25,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Malgorzata Monika Trawinska",
            "author_affiliations": [
                "Hematology, S. Eugenio Hospital, Tor Vergata University, ASL Roma2, Rome, Italy"
            ],
            "author_rank": 26,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Antonio Cuneo",
            "author_affiliations": [
                "Division of Hematology, Department of Medical Sciences, University of Ferrara, Azienda Ospedaliera-Universitaria, Arcispedale S. Anna, Ferrara, Italy"
            ],
            "author_rank": 27,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Monica Bocchia",
            "author_affiliations": [
                "Policlinico S. Maria alle Scotte, AOU Senese, Siena, Italy"
            ],
            "author_rank": 28,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Mauro Krampera",
            "author_affiliations": [
                "A.O.U. Integrata Verona, Verona, Italy"
            ],
            "author_rank": 29,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Fabrizio Pane",
            "author_affiliations": [
                "Azienda Ospedaliera Universitaria Federico II, Naples, Italy"
            ],
            "author_rank": 30,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Roberto M. Lemoli",
            "author_affiliations": [
                "Dipartimento di Medicina interna e Specialit\u00e0 mediche, Universit\u00e0 di Genova, Genova, Italy",
                "IRCCS Policlinico San Martino, Genoa, Italy"
            ],
            "author_rank": 31,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Daniela Cilloni",
            "author_affiliations": [
                "AOU San Luigi Gonzaga, Turin, Italy",
                "A.O. Ordine Mauriziano di Torino, Turin, Italy"
            ],
            "author_rank": 32,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Michele Cavo",
            "author_affiliations": [
                "Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale, Universit\u00e0 di Bologna, Bologna, Italy",
                "IRCCS Azienda ospedaliero-universitaria di Bologna, Istituto di Ematologia \"Ser\u00e0gnoli\", Bologna, Italy"
            ],
            "author_rank": 33,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Nicola Vianelli",
            "author_affiliations": [
                "IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia \"Ser\u00e0gnoli\", Bologna, Italy"
            ],
            "author_rank": 34,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Giuseppe A. Palumbo",
            "author_affiliations": [
                "Dipartimento di Scienze Mediche Chirurgiche e Tecnologie Avanzate \"G.F. Ingrassia\", Universit\u00e0 degli Studi di Catania, Catania, Italy"
            ],
            "author_rank": 35,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Massimo Breccia",
            "author_affiliations": [
                "Hematology, Department of Translational and Precision Medicine, Azienda Ospedaliera Policlinico Umberto I, Sapienza University of Rome, Rome, Italy"
            ],
            "author_rank": 36,
            "first_author": 0,
            "last_author": 1
        }
    ],
    "datetime_abstract_obtained": "2022-06-22T18:40:16",
    "is_scraped": "1"
}